{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:04:03Z","timestamp":1793639043607,"version":"4.5.1"},"reference-count":30,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,9,19]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Genetic variations in the alternative pathway of complement may be associated with thrombotic microangiopathy in children receiving HSCT. These findings may guide the development of novel treatment interventions for this poorly understood transplant complication.<\/jats:p>","DOI":"10.1182\/blood-2013-05-501445","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T03:26:48Z","timestamp":1372476408000},"page":"2003-2007","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":221,"title":["Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy"],"prefix":"10.1182","volume":"122","author":[{"given":"Sonata","family":"Jodele","sequence":"first","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Licht","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Goebel","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley P.","family":"Dixon","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Human Genetics, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theru A.","family":"Sivakumaran","sequence":"additional","affiliation":[{"name":"Division of Human Genetics, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred G.","family":"Pluthero","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Laskin","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Children\u2019s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111818290716600_B1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"issue":"1 Suppl 1","key":"2019111818290716600_B2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","article-title":"The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation.","volume":"14","author":"Cooke","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2019111818290716600_B3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00467-010-1637-4","article-title":"Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.","volume":"26","author":"Keir","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2019111818290716600_B4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-010-1556-4","article-title":"aHUS caused by complement dysregulation: new therapies on the horizon.","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"2019111818290716600_B5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2012.09.006","article-title":"Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome.","volume":"126","author":"Tsai","year":"2013","journal-title":"Am J Med"},{"issue":"2","key":"2019111818290716600_B6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis.","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2019111818290716600_B7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","article-title":"Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study.","volume":"85","author":"Siami","year":"2008","journal-title":"Transplantation"},{"issue":"11","key":"2019111818290716600_B8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/bmt.2008.7","article-title":"Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder.","volume":"41","author":"George","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111818290716600_B9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"2019111818290716600_B10","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1111\/j.1399-3046.2010.01408.x","article-title":"Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.","volume":"16","author":"Jodele","year":"2012","journal-title":"Pediatr Transplant"},{"issue":"7","key":"2019111818290716600_B11","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1681\/ASN.2006020118","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment.","volume":"17","author":"Hingorani","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2019111818290716600_B12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bmt.1705643","article-title":"Significant increase in end-stage renal disease after hematopoietic stem cell transplantation.","volume":"39","author":"Cohen","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111818290716600_B13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2019111818290716600_B14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJMc1106619","article-title":"Eculizumab and refractory membranoproliferative glomerulonephritis.","volume":"366","author":"Radhakrishnan","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111818290716600_B15","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency.","volume":"111","author":"J\u00f3zsi","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111818290716600_B16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0030-1262884","article-title":"The autoimmune disease DEAP-hemolytic uremic syndrome.","volume":"36","author":"Skerka","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"2019111818290716600_B17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"issue":"8","key":"2019111818290716600_B18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2019111818290716600_B19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","article-title":"Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?","volume":"53","author":"Jodele","year":"2013","journal-title":"Transfusion"},{"issue":"5","key":"2019111818290716600_B20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/bmt.2010.182","article-title":"Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.","volume":"46","author":"Laskin","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2019111818290716600_B21","doi-asserted-by":"crossref","first-page":"e53830","DOI":"10.1371\/journal.pone.0053830","article-title":"Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.","volume":"8","author":"Holliday","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"2019111818290716600_B22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111818290716600_B23","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00467-010-1446-9","article-title":"DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome.","volume":"25","author":"Zipfel","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"19","key":"2019111818290716600_B24","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","article-title":"Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.","volume":"114","author":"Abarrategui-Garrido","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111818290716600_B25","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar4016","article-title":"Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.","volume":"14","author":"Foltyn Zadura","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"2019111818290716600_B26","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","article-title":"Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation.","volume":"114","author":"Heinen","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111818290716600_B27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2011.152","article-title":"Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.","volume":"80","author":"Strobel","year":"2011","journal-title":"Kidney Int"},{"issue":"3","key":"2019111818290716600_B28","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1111\/ctr.12102","article-title":"The use of eculizumab in renal transplantation.","volume":"27","author":"Barnett","year":"2013","journal-title":"Clin Transplant"},{"issue":"2","key":"2019111818290716600_B29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome.","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"issue":"2","key":"2019111818290716600_B30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/bjh.12202","article-title":"Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.","volume":"161","author":"Peffault de Latour","year":"2013","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/12\/2003\/1368492\/2003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/12\/2003\/1368492\/2003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T18:29:29Z","timestamp":1574101769000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/122\/12\/2003\/31644\/Abnormalities-in-the-alternative-pathway-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,19]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,9,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2013-05-501445","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,19]]}}}